{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:15:03Z","timestamp":1791900903198,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s11064-019-02814-4","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T07:04:30Z","timestamp":1558076670000},"page":"1773-1779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Protective Effects of Levetiracetam on a Human iPSCs-Derived Spinal Muscular Atrophy Model"],"prefix":"10.1007","volume":"44","author":[{"given":"Shiori","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Funato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuru","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahide","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"2814_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97\u2013110","journal-title":"Neurobiol Dis"},{"key":"2814_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"2814_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s004390100473","volume":"108","author":"CF Rochette","year":"2001","unstructured":"Rochette CF, Gilbert N, Simard LR (2001) SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum Genet 108:255\u2013266","journal-title":"Hum Genet"},{"key":"2814_CR4","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96:6307\u20136311","journal-title":"Proc Natl Acad Sci USA"},{"key":"2814_CR5","doi-asserted-by":"publisher","first-page":"11167","DOI":"10.1073\/pnas.96.20.11167","volume":"96","author":"L Pellizzoni","year":"1999","unstructured":"Pellizzoni L, Charroux B, Dreyfuss G (1999) SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci USA 96:11167\u201311172","journal-title":"Proc Natl Acad Sci USA"},{"key":"2814_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0960-8966(97)00459-8","volume":"7","author":"K Zerres","year":"1997","unstructured":"Zerres K, Wirth B, Rudnik-Schoneborn S (1997) Spinal muscular atrophy\u2014clinical and genetic correlations. Neuromuscul Disord 7:202\u2013207","journal-title":"Neuromuscul Disord"},{"key":"2814_CR7","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC et al (2016) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388:3017\u20133026","journal-title":"Lancet"},{"key":"2814_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH et al (2000) A mouse model for spinal muscular atrophy. Nat Genet 24:66\u201370","journal-title":"Nat Genet"},{"key":"2814_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD et al (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54:647\u2013654","journal-title":"Ann Neurol"},{"key":"2814_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA et al (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277\u2013280","journal-title":"Nature"},{"key":"2814_CR11","doi-asserted-by":"publisher","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","volume":"7","author":"D Sareen","year":"2012","unstructured":"Sareen D, Ebert AD, Heins BM, McGivern JV, Ornelas L, Svendsen CN (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS ONE 7:e39113","journal-title":"PLoS ONE"},{"key":"2814_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5966\/sctm.2015-0059","volume":"5","author":"K Ohuchi","year":"2016","unstructured":"Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y et al (2016) Established stem cell model of spinal muscular atrophy is applicable in the evaluation of the efficacy of thyrotropin-releasing hormone analog. Stem Cells Transl Med 5:152\u2013163","journal-title":"Stem Cells Transl Med"},{"key":"2814_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejphar.2017.08.005","volume":"81","author":"S Ando","year":"2017","unstructured":"Ando S, Funato M, Ohuchi K, Kameyama T, Inagaki S, Seki J et al (2017) Edaravone is a candidate agent for spinal muscular atrophy: in vitro analysis using a human induced pluripotent stem cells-derived disease model. Eur J Pharmacol 81:161\u2013168","journal-title":"Eur J Pharmacol"},{"key":"2814_CR14","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861\u20139866","journal-title":"Proc Natl Acad Sci USA"},{"key":"2814_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","volume":"43","author":"EA Lukyanetz","year":"2002","unstructured":"Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9\u201318","journal-title":"Epilepsia"},{"key":"2814_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jnc.13405","volume":"136","author":"I Miyazaki","year":"2016","unstructured":"Miyazaki I, Murakami S, Torigoe N, Kitamura Y, Asanuma M (2016) Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice. J Neurochem 136:194\u2013204","journal-title":"J Neurochem"},{"key":"2814_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-150687","volume":"50","author":"C Stockburger","year":"2016","unstructured":"Stockburger C, Miano D, Baeumlisberger M, Pallas T, Arrey TN, Karas M et al (2016) A mitochondrial role of SV2a protein in aging and alzheimer's disease: studies with levetiracetam. J Alzheimers Dis 50:201\u2013215","journal-title":"J Alzheimers Dis"},{"key":"2814_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s10157-007-0495-2","volume":"11","author":"A Hishida","year":"2007","unstructured":"Hishida A (2007) Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance. Clin Exp Nephrol 11:292\u2013296","journal-title":"Clin Exp Nephrol"},{"key":"2814_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1528-1167.2011.03300.x","volume":"53","author":"N Delanty","year":"2012","unstructured":"Delanty N, Jones J, Tonner F (2012) Adjunctive levetriacetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Epilepsia 53:111\u2013119","journal-title":"Epilepsia"},{"key":"2814_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1073\/pnas.1014918108","volume":"108","author":"H Yamamoto","year":"2011","unstructured":"Yamamoto H, Itoh N, Kawano S, Yatsukawa Y, Momose T, Makio T et al (2011) Dual role of the receptor Tom20 in specificity and efficiency of protein import into mitochondria. Proc Natl Acad Sci USA 108:91\u201396","journal-title":"Proc Natl Acad Sci USA"},{"key":"2814_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF03033366","volume":"13","author":"GC Parker","year":"2008","unstructured":"Parker GC, Li X, Anguelov RA, Toth G, Cristescu A, Acsadi G (2008) Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. Neurotox Res 13:39\u201348","journal-title":"Neurotox Res"},{"key":"2814_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","volume":"80","author":"N Roy","year":"1995","unstructured":"Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R et al (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167\u2013178","journal-title":"Cell"},{"key":"2814_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"2814_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"S Eyal","year":"2004","unstructured":"Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M (2004) The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45:737\u2013744","journal-title":"Epilepsia"},{"key":"2814_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ (2004) Cell\u00a0death: critical control points. Cell 116:205\u2013219","journal-title":"Cell"},{"key":"2814_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0014-5793(01)02199-8","volume":"492","author":"S Salvioli","year":"2001","unstructured":"Salvioli S, Bonaf\u00e8 M, Capri M, Monti D, Franceschi C (2001) Mitochondria, aging and longevity\u2014a new perspective. FEBS Lett 492:9\u201313","journal-title":"FEBS Lett"},{"key":"2814_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel GS, Horvath TL (2015) Mitochondrial ROS signaling in organismal homeostasis. Cell 163:560\u2013569","journal-title":"Cell"},{"key":"2814_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1742-4658.2005.05103.x","volume":"273","author":"C Chinopoulos","year":"2006","unstructured":"Chinopoulos C, Adam-Vizi V (2006) Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J 273:433\u2013450","journal-title":"FEBS J"},{"key":"2814_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.1425","volume":"106","author":"M Orth","year":"2001","unstructured":"Orth M, Schapira AH (2001) Mitochondria and degenerative disorders. Am J Med Genet 106:27\u201336.","journal-title":"Am J Med Genet"},{"key":"2814_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/17482968.2012.648645","volume":"13","author":"S Pickles","year":"2012","unstructured":"Pickles S, Vande Velde C (2012) Misfolded SOD1 and ALS: zeroing in on mitochondria. Amyotroph Lateral Scler 13:333\u2013340","journal-title":"Amyotroph Lateral Scler"},{"key":"2814_CR31","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/jnr.22106","volume":"87","author":"G Acsadi","year":"2009","unstructured":"Acsadi G, Lee I, Li X, Khaidakov M, Pecinova A, Parker GC et al (2009) Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res 87:2748\u20132756","journal-title":"J Neurosci Res"},{"key":"2814_CR32","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1093\/hmg\/ddw262","volume":"25","author":"N Miller","year":"2016","unstructured":"Miller N, Shi H, Zelikovich AS, Ma YC (2016) Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum Mol Genet 25:3395\u20133406","journal-title":"Hum Mol Genet"},{"key":"2814_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/ph3020345","volume":"3","author":"T Bordet","year":"2010","unstructured":"Bordet T, Berna P, Abitbol JL, Pruss RM (2010) Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals 3:345\u2013368","journal-title":"Pharmaceuticals"},{"key":"2814_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.15252\/embr.201439820","volume":"16","author":"JR Liang","year":"2015","unstructured":"Liang JR, Martinez A, Lane JD, Mayor U, Clague MJ, Urb\u00e9 S (2015) USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. EMBO Rep 16:618\u2013627","journal-title":"EMBO Rep"},{"key":"2814_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2013.02.012","volume":"54","author":"R Magnoni","year":"2013","unstructured":"Magnoni R, Palmfeldt J, Christensen JH, Sand M, Maltecca F, Corydon TJ, West M, Casari G, Bross P (2013) Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice. Neurobiol Dis 54:12\u201323","journal-title":"Neurobiol Dis"},{"key":"2814_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02814-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02814-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02814-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:26:50Z","timestamp":1589570810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02814-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2814"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02814-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The procedures used in the experiments on human induced pluripotent stem cells (Control iPSCs; 201B7 line) adhered to the tenets of the Declaration of Helsinki. The 201B7 line was generated from adult human dermal fibroblasts which was purchased from Cell Applications, Inc (San Diego, CA, USA) [\n                      \n                      ]. The somatic cells collection from the patients, the establishment of patient-derived iPSCs, and pathological analysis of differentiated iPSCs including evaluation of the potential drug efficacy were planned in this study. These planed protocols were approved by the Ethics Review Committee of the National Hospital Organization, Nagara Medical Center (Approval Number: 26-15), and informed consents were obtained from the parents of our pediatric patients. Informed consents were obtained from the subjects after explanation of the nature and possible consequences of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}]}}